期刊文献+

原发性肾病综合征患儿槐杞黄颗粒治疗前后血清细胞因子变化的研究 被引量:22

Effect of Huaiqihuang particles on serum TNF-α,IL-18 and IL-10 in children with primary nephrotic syndrome
原文传递
导出
摘要 目的观察原发性肾病综合征(PNS)患儿血清肿瘤坏死因子(TNF-α)、白细胞介素(IL)-18、IL-10的动态变化,及槐杞黄颗粒对炎症因子和感染、复发的影响。方法2008-06-01—2009-07-31收治于中国医科大学附属盛京医院小儿肾内科的初发PNS患儿67例,随机分为两组:槐杞黄组35例,给予泼尼松加槐杞黄颗粒口服;激素组32例,单纯给予泼尼松口服。观察两组治疗前,治疗0.5、1、3和6个月血清TNF-α、IL-18、IL-10的动态变化,并记录1年内感染和复发次数。健康体检儿童25名为对照组。采用ELISA方法检测血清TNF-α、IL-18、IL-10。结果(1)槐杞黄组感染次数(19例次)明显少于激素组(58例次),槐杞黄组复发例数(7例,20%)明显少于激素组(12例,37.5%)。(2)治疗前两组未复发病例TNF-α显著高于对照组,差异有统计学意义(P<0.05);0.5个月时两组均显著下降至正常水平(P<0.05),之后无明显变化,组间无差异。(3)治疗前两组未复发病例IL-18明显高于对照组,差异有统计学意义(P<0.05);至3个月后槐杞黄组显著降低(P<0.05),并低于激素组,但仍明显高于对照组(P<0.05)。(4)治疗前两组未复发病例IL-10显著低于对照组,差异有统计学意义(P<0.05);0.5个月时槐杞黄组、激素组均明显降低,分别为(6.75±1.77)pg/mL、(7.79±3.01)pg/mL,且低于治疗前(P<0.05),两组间差异无统计学意义;至6个月时槐杞黄组明显上升([13.29±7.19)pg/mL]且高于激素组([7.48±3.04)pg/mL(]P<0.05)及治疗前,仍未达到正常水平。(5)复发病例中,槐杞黄组TNF-α显著低于激素组(P<0.05),两组IL-10及IL-18差异无统计学意义。结论TNF-α、IL-18、IL-10参与PNS的发病,致炎因子/抑炎因子失衡可能是PNS的发病机制之一。槐杞黄颗粒可能通过降低IL-18的致炎作用,增强IL-10的抑炎作用,从而减少PNS患儿感染及复发。 Objective To observe the dynamic changes of serum TNF-α , IL-18 and IL-10 in children with primary nephrotie syndrome (PNS) and the effect of Huaiqihuang particles on these inflammatory factors , infection and relapse of the patients. Methods TotalLy 67 patients first diagnosed with PNS were randomly divided into group A (35 eases) and group B (32 cases). Group A was treated with prednisone and Huaiqihuang particles, while group B was treated with prednisone only. Observe the serum TNF-α , IL-18 and IL-10 level before the treatment, 0.5 month, 1 month, 3 months and 6 months after treatment. Record the infection and relapse patients within 1 year. Group C was control group (25 healthy children). Serum TNF-α , IL-18 and IL-10 level was detected by ELISA. Results (1)The infection times of group A (0.54 time each patient)were significantly fewer than group B ( 1.81time each patient), and the relapse cases of group A (7, 37.5% ) were fewer than group B ( 12, 37.5% ). (2) TNF-α : Before treatment, the serum level was higher than group C (P 〈 0.05) ; 0.5 month after treatment, it decreased to normal in both group A and B (P 〈 0.05) , then maintained at normal level; there were no differences between the two groups. (3)IL-18 : Before treatment, the serum level of groups A and B was higher than group C (P 〈 0.05) ; it decreased significantly after 3 months' treatment (P 〈 0.05)in group A, which was lower than that of group B but still higher than that of group C (P 〈 0.05). (4)IL-10: Before treatment, the serum level of the gwo groups was higher than group C (P 〈 0.05) ; 0.5 month after treatment, it decreased in both group A and B (P 〈 0.05) ; there were no differences between the lwo groups. Six months after treatment, it increased significantly in group A , higher than group B (P 〈 0.05 ), but still did not reach the normal level. ( 5 ) Relapse cases : Serum TNF-α level in group A was lower than that of group B (P 〈 0.05 ). There were no differences between the two groups in IL-18 and IL-10 level. Conclusion TNF-α , IL-18 and IL-10 participate in the pathogenesis of PNS. The imbalance of inflammatory factors and inhibited factors may he one of the pathogenesis of PNS. Huaiqihuang particles can prevent the infection and relapse of PNS children, by reducing the inflammatory effects of IL-18 and enhancing the inhibitory effects of IL-10.
出处 《中国实用儿科杂志》 CSCD 北大核心 2010年第1期33-36,共4页 Chinese Journal of Practical Pediatrics
基金 辽宁省科学技术计划项目(2008225010-8)
关键词 原发性肾病综合征 肿瘤坏死因子α 白细胞介素18 白细胞介素10 槐杞黄颗粒 primary nephrotic syndrome (PNS) TNF-α IL- 18 IL- 10 Huaiqihuang particles
  • 相关文献

参考文献18

  • 1Bakr A, Shokeir M, EI-Chenawi F, et al. Tumor necrosis factor- α production from mononuclear cells in nephrotic syndrome [ J ]. Pediatr Nephrol, 2003,18: 516-520.
  • 2Cho MH, Lee HS, Choe BH, et al. Interleukin-8 and tumor necrosis factor-alpha are increased in minimal change disease bat do not alter albumin permeability [J]. Am J Nephrol, 2003, 23: 260-266.
  • 3Mastsumoto K, Kanmatsuse K. Elevated interleukin-18 levels in the urine of nephritic patients[J]. Nephron , 2001 , 88 (4) : 334-339.
  • 4Kilis-Pstrusinska K, Medynska A, Zwolinska D, et al Interleukin-18 in urine and serum of children with idiopathic nephrotie syndrome[J]. Kidney Blood Press Res,2008,31 : 122-126.
  • 5韩志英.槐杞黄颗粒治疗小儿反复呼吸道感染50例[J].中国中西医结合杂志,2004,24(6):563-564. 被引量:23
  • 6黄琼.还尔金-槐杞黄颗粒治疗脑瘫患儿反复呼吸道感染62例疗效观察[J].河南中医学院学报,2004,19(4):65-65. 被引量:6
  • 7中华医学会儿科学分会肾脏病学组,姚勇,杨霁云,陈述枚,丁洁.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39(12):746-749. 被引量:1538
  • 8Drewe E, McDermott EM, Powell RJ. Treatment of the nephrotic syndrome with Etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome [J]. N Eng J Med, 2000,343 : 1044-1045.
  • 9Lama G, Luongo I, Tirino G, et al. T-lymphocyte populations and cytokines in childhood nephrotic syndrome [J]. Am J Kidney Dis, 2002,5: 958-965.
  • 10Laflam PF, Garin EH. Effect of tumor necrosis factor α and vascular permeability growth factor on albuminuria in rats [J]. Pediatr Nephrol,2006,21 : 177-181.

共引文献1564

同被引文献229

引证文献22

二级引证文献170

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部